查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008855

核苷酸市場報告：按類型、技術、形式、應用和地區分類（2026-2034 年）

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2025年全球核苷酸市場規模達8.085億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到13.312億美元，2026年至2034年的複合年成長率（CAGR）為5.53%。北美是該市場的關鍵區域，這主要得益於生物技術和新生兒營養學領域的進步。此外，嬰幼兒營養食品需求的成長以及動物飼料使用量的增加也支撐著市場發展。同時，機能性食品和飲料需求的成長也促進了市場成長。

核苷酸市場趨勢：

核苷酸療法市場的擴張

隨著對核苷酸在治療遺傳疾病、癌症和病毒性疾病方面的潛力研究不斷深入，核苷酸治療方法市場正在擴張。各公司正致力於利用核苷酸開發mRNA疫苗、RNA療法和基因編輯工具。隨著生物製藥公司專注於這些新治療方法，對核苷酸市場的投資也不斷增加。基於核苷酸序列的「叢集規律間隔短回文重複序列（CRISPR）」技術的進步也推動了市場成長。這項發展促使製藥公司開發基於核苷酸的治療方法，以透過個人化醫療改善患者預後。隨著全球醫療產業日益重視對更具靶向性和有效性的藥物的需求，尤其是在腫瘤學和罕見遺傳疾病領域，市場持續成長，從而導致對核苷酸治療方法的需求不斷增加。 2024 年，專注於開發 Nuvec®（一種用於癌症治療和疫苗的創新核苷酸運輸遞送機制）的製藥公司 N4 Pharma 與 SRI 建立了研究合作夥伴關係，將 Nuvec 與 SRI 的專有 FOX Three 分子引導系統™ (MGS) 相結合，並計劃共同推廣這項整合技術。

擴大生物技術領域的研究和開發活動

生物技術領域的研發活動正在推動核苷酸市場的發展。科學家不斷研究核苷酸在DNA和RNA合成、基因表現以及疾病機制中的功能。生物技術領域投資的增加正在推動研發的爆炸性成長，從而催生出高度先進的核苷酸類產品。學術機構和實驗室正在開發新型核苷酸類似物和改進的合成技術。這項科學在發現新的候選藥物以及拓展核苷酸在診斷、疫苗和治療領域的應用方面發揮著至關重要的作用。隨著各國政府和私營機構致力於推動生物技術的發展，對高品質核苷酸試劑和工具的需求穩步成長，推動全球市場的發展。 2024年，印度政府核准了“BioE3（生物技術促進經濟、環境和就業）政策”，旨在促進創新研究，並加強高效生物製造領域的創業精神。

精準醫療領域的創新進展

精準醫療的興起正在推動核苷酸市場的成長。隨著個人化醫療（根據個人基因譜量身定做的醫療方案）的不斷發展，對基於核苷酸的診斷和治療方法的需求日益成長。基於核苷酸的基因檢測能夠識別個別特定的基因突變，從而深入了解患者的疾病易感性。這有助於開發更精準的個人化治療方法。科學家正致力於研究如何使基於核苷酸的療法更加個人化，以提高治療的安全性和有效性。精準醫療的進步推動了對引子、探針和酵素分子等核苷酸產品的需求成長，進一步促進了市場發展。 IMARC Group預測，到2033年，全球精準醫療市場規模將達1,794億美元。

核苷酸市場成長促進因素：

擴大DNA和RNA合成的應用

DNA和RNA合成技術的日益普及正在推動核苷酸市場的成長。核苷酸是DNA和RNA的前體，在基因合成、克隆和定序領域的應用日益廣泛。隨著遺傳學的進步，研究人員擴大利用核苷酸合成技術來建立個人化的DNA和RNA鏈，用於評估基因功能和調控基因表現。合成生物學在農業、製藥和環境科學領域的應用不斷拓展，也推動了市場需求。各公司在高品質、高階核苷酸合成設備的供應方面不斷創新，從而拓寬了市場前景。合成生物學的發展透過增加建構基因序列所需的核苷酸需求，推動了市場成長。

對感染疾病調查的關注度日益提高

核苷酸市場的主要驅動力是感染疾病研發需求的不斷成長，尤其是在全球疫情大流行之後。科學家正擴大利用核苷酸開發診斷設備、疫苗和抗病毒藥物。例如，寡核苷酸等核苷酸類產品正被用於建構分子診斷試劑盒和病原體鑑定試劑盒。隨著對快速、高品質且可擴展的感染疾病管理解決方案的需求日益成長，核苷酸類產品的應用正在迅速發展。隨著人們對開發感染疾病新治療方法的持續關注，核苷酸市場必將繼續在全球疾病防治工作中發揮關鍵作用。

核苷酸合成與純化技術的發展

核苷酸市場的發展主要得益於核苷酸合成和純化技術的進步。自動化、高通量定序和核酸萃取方法方法的創新，使得核苷酸的生產更經濟高效。新的核苷酸純化技術也提高了最終產品的質量，這對科學研究、診斷和藥物研發至關重要。市場參與者的持續創新推動了更擴充性和高精度的核苷酸純化和合成技術的發展。這些進步使研究人員和生物製藥公司能夠獲得基於核苷酸的研發所需的核苷酸，從而加速其在包括個人化醫療在內的眾多領域的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球核苷酸市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 食品級
  • 實驗室級
  • 工業級
  • 其他

第7章 市場區隔：依技術分類

  • TaqMan等位基因鑑定
  • 基因晶片和微陣列
  • SNP：焦磷酸測序法
  • 其他

第8章 市場區隔：依形式

  • 液體
  • 粉末

第9章 市場區隔：依應用領域分類

  • 製藥
  • 食品和飼料添加劑
  • 藥物發現
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • CJ CheilJedang Corporation
    • Exotic Biosolutions
    • F. Hoffmann-La Roche AG
    • Jena Bioscience GmbH
    • Koninklijke DSM NV
    • Lallemand Inc.
    • Meridian Bioscience Inc.
    • Nanjing Biotogether Co. Ltd.
    • Ohly GmbH（Associated British Foods plc）
    • Promega Corporation
    • Starlake Bioscience Co. Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6472

The global nucleotides market size reached USD 808.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,331.2 Million by 2034, exhibiting a growth rate (CAGR) of 5.53% during 2026-2034. North America represents the leading region driven by advancements in biotechnology and newborn nutrition. Moreover, the rising demand for infant nutrition and the increasing use of animal feed are supporting the market. Additionally, the heightened demand for functional food and beverages is strengthening the market growth.

NUCLEOTIDES MARKET ANALYSIS:

  • Major Market Drivers: The expansion of functional foods and beverages is propelling the market.
  • Key Market Trends: The growing use of nucleotide supplements in dairy products is acting as a significant growth-inducing factor.
  • Competitive Landscape: Some of the major market companies include CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc., and Thermo Fisher Scientific Inc., among many others.
  • Geographical Trends: The market in North America is driven by advancements in biotechnology and newborn nutrition. Asia-Pacific is witnessing significant demand due to growth in the pharmaceutical and animal feed businesses. Europe emphasizes functional meals and infant formulas, while Latin America benefits from increasing nucleotide use in animal feed. Furthermore, the Middle East and Africa area is undergoing moderate market expansion, primarily in healthcare and nutrition.
  • Challenges and Opportunities: The high production cost is hampering the market. However, improving manufacturing procedures and boosting productivity to achieve cost-effectiveness will continue to catalyze the market over the forecast period.

NUCLEOTIDES MARKET TRENDS:

Growing Market for Nucleotide Therapeutics

The market for nucleotide-based therapies is growing as researchers are learning more about the ability to treat genetic diseases, cancers, and viral diseases with nucleotides. Companies are working on mRNA vaccines, RNA therapies, and gene editing tools involving nucleotides. Since biopharmaceutical businesses are concentrating on these new therapies, investments in the market for nucleotides are growing. Progress in the technology for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), which is based on the nucleotide sequence, is also supporting the market growth. This force is urging pharmaceutical businesses to develop nucleotide-based therapies, which will enhance the outcomes for the patient through personalized medicine. The market is always growing as the world's healthcare industry places greater importance on the requirement for more focused and effective medicine, especially in the area of oncology and rare genetic conditions, with the result that the demand for nucleotide-based therapies grows. In 2024, N4 Pharma, a pharmaceutical specialist focused on creating Nuvec(R), an innovative delivery mechanism intended for transporting nucleotides for cancer therapies and vaccines, established a research collaboration with SRI to integrate Nuvec with SRI's exclusive FOX Three Molecular Guidance System(TM) (MGS), aiming to jointly market the integrated technology.

Increasing Biotech Research and Development Activities

Researche and development (R&D) activities in the biotech sector are driving the market for nucleotides. Scientists are always researching on the nucleotides due to their function in DNA and RNA synthesis, gene expression, and the mechanisms of diseases. Increased investments in biotechnology fields are aiding this explosion in R&D, thus emerging with highly advanced nucleotide-based products. Academic institutions and laboratories are conducting the development of novel nucleotide analogs and better synthesis techniques. This science is key in the identification of novel drug candidates and the growth in the application of nucleotides in diagnostics, vaccines, and therapies. With governments and private institutions targeting the advancement in biotech, the need for high-quality nucleotide reagents and tools is steadily increasing, thereby driving the market across the world. In 2024, The Government of India approved BioE3 (Biotechnology for Economy, Environment, and Employment) Policy, which aimed to enhance innovation-oriented research and entrepreneurship in high-efficiency biomanufacturing.

Innovative Developments in Precision Medicine

Rise in precision medicine is driving the market for nucleotides. With increasingly individualized medicine becoming tailored to the individual's genetic profile, there is growing demand for nucleotide-based diagnostics and therapies. Genetic testing using nucleotides is identifying the particular genetic mutation in an individual and offering insights into the patient's predisposition to diseases. This helps create better tailored therapies. Scientists are increasingly investigating how therapies involving nucleotides need to be increasingly individualized in order to enhance the safety and efficacy of the therapies. With the improvement in precision medicine, the need for nucleotides in the form of primers, probes, and enzyme molecules is on the rise, thus propelling the market growth. IMARC Group predicts that the global precision medicine market is projected to attain USD 179.4 Billion by 2033.

NUCLEOTIDES MARKET GROWTH DRIVERS:

Growing Use of DNA and RNA Synthesis

Utilization of DNA and RNA synthesis technology is driving the market for nucleotides. Nucleotides are the precursors for DNA and RNA, and the use in the field of gene synthesis, cloning, and sequencing is growing. With the growing advancement in the field of genetics, researchers are increasingly using nucleotide synthesis in the construction of personalized DNA and RNA strands for the purpose of evaluating the function of the gene and the regulation of the expression of the gene. Expanded use of synthetic biology for agricultural, pharmaceutical, and environmental science purposes is also driving the demand. Firms are innovating in the supply of quality, high-end nucleotide synthesis equipment, and this is expanding market prospects. With the growth in synthetic biology, the demand for nucleotides for the construction of the sequence in the genes is increasingly growing, driving the market.

Increased Emphasis on Researching Infectious Diseases

The increasing need for infectious diseases research, particularly after the pandemic in the world, is primarily responsible for the market for nucleotides. Scientists are increasingly using nucleotides for diagnostic device development, vaccines, and antiviral drug development. Nucleotides-based products, for example, oligonucleotides, are used for the construction of molecular diagnostics and pathogen identification kits. With the increasing need for quick, qualitative, and scalable solutions for emerging infectious disease management, the application of nucleotide-based products is advancing at a fast pace. Continued interest in the identification of new treatments for infectious diseases ensures that the market for nucleotides continues to be one of the most vital participants in the world's disease management activities.

Technology Developments for Nucleotide Synthesis and Purification

The market for nucleotides has been driven by the progress in technology for the synthesis and purification of nucleotides. Innovations in the field of automation, high-throughput sequencing, and extraction methods for nucleic acids are facilitating the most economical and efficient production of nucleotides. Emerging methods for the purification of nucleotides are also increasing the quality of the final outputs, which is vital for application in research, diagnostics, and drug development. There is constant innovation by players in this market, which is facilitating the creation of increasingly scalable and accurate techniques for purifying and synthesizing nucleotides. Such advancements are allowing researchers and biopharmaceutical businesses to access the nucleotides for the purpose of working with the nucleotides, driving their application across many ends such as drug discovery through personalized medicine.

GLOBAL NUCLEOTIDES INDUSTRY SEGMENTATION:

Breakup by Type:

  • Food Grade
  • Lab Grade
  • Industry Grade
  • Others

Food grade nucleotides are commonly employed in infant formulae and functional meals, while lab grade nucleotides are required for scientific and medicinal uses. Furthermore, industry grade nucleotides are utilized in animal feed to increase livestock welfare and development, particularly in aquaculture and poultry production.

Breakup by Technology:

  • TaqMan Allelic Discrimination
  • Gene Chips and Microarrays
  • SNP by Pyrosequencing
  • Others

TaqMan allelic discrimination improves SNP detection accuracy. Gene chips and microarrays enable high-throughput genotyping and comprehensive genetic analysis. Additionally, SNP by pyrosequencing provides precise sequencing capabilities, which accelerates research and diagnosis. Together, these innovations are helping to drive the nucleotides market statistics.

Breakup by Form:

  • Liquid
  • Powder

Liquid nucleotides are easy to handle and dissolve quickly, making them appropriate for research and therapeutic settings. In contrast, powder nucleotides have a longer shelf life and can be used in a variety of formulations. This dual offering improves market accessibility while also advancing biotechnology and molecular biology, thereby inflating the nucleotides market revenue.

Breakup by Application:

  • Pharmaceutical
  • Food and Animal Feed Additives
  • Drug Discovery
  • Others

The market is driven by the increasing pharmaceuticals industry, where nucleotides play an important role in drug formulation and development. In food and animal feed additives, nucleotides are important additions for improving nutritional content and digestive health in animal feed. Furthermore, their importance in drug discovery hastens the identification of therapeutic targets, pushing advances in biotechnology and healthcare. These segments are bolstering the nucleotides market demand.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The nucleotides market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The nucleotide market in North America benefits from strong research centers and considerable pharmaceutical investments. Asia-Pacific is rising rapidly due to increased demand in biotechnology and the healthcare sector. Europe benefits from strong regulatory support and a thriving pharmaceutical industry, which drives nucleotide innovation. Latin America is poised for expansion, backed by increased health awareness and agricultural uses. The Middle East and Africa are steadily evolving, with a growing interest in biotechnology and nutritional upgrades for food and feed.

COMPETITIVE LANDSCAPE:

As per the nucleotides market overview, the market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • CJ CheilJedang Corporation
  • Exotic Biosolutions
  • F. Hoffmann-La Roche AG
  • Jena Bioscience GmbH
  • Koninklijke DSM N.V.
  • Lallemand Inc.
  • Meridian Bioscience Inc.
  • Nanjing Biotogether Co. Ltd.
  • Ohly GmbH (Associated British Foods plc)
  • Promega Corporation
  • Starlake Bioscience Co. Inc.
  • Thermo Fisher Scientific Inc.

()

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global nucleotides market performed so far, and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleotides market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the form?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleotides market, and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nucleotides Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Food Grade
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lab Grade
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Industry Grade
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 TaqMan Allelic Discrimination
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gene Chips and Microarrays
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNP by Pyrosequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Form

  • 8.1 Liquid
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Powder
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Pharmaceutical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Food and Animal Feed Additives
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Drug Discovery
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CJ CheilJedang Corporation
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Exotic Biosolutions
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 F. Hoffmann-La Roche AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Jena Bioscience GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Koninklijke DSM N.V.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Lallemand Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Meridian Bioscience Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Nanjing Biotogether Co. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Ohly GmbH (Associated British Foods plc)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Promega Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Starlake Bioscience Co. Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
  • Figure 2: Global: Nucleotides Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2025
  • Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: North America: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: United States: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Canada: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: China: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Japan: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: India: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: South Korea: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Australia: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Europe: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Germany: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: France: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Italy: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Spain: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Russia: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Latin America: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Brazil: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Mexico: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Others: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2025
  • Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Global: Nucleotides Industry: SWOT Analysis
  • Figure 87: Global: Nucleotides Industry: Value Chain Analysis
  • Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nucleotides Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million USD), 2026-2034
  • Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Nucleotides Market: Competitive Structure
  • Table 8: Global: Nucleotides Market: Key Players